FDAClass IIFebruary 1, 2023

Asthmanefrin Racepinephrine Inhalation Solution recall

Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator (racephedrine, USP 11.25), 30x0.5 mL Sterile Vials each in a foil pouch, NDC…

Why was Asthmanefrin Racepinephrine Inhalation Solution recalled?

Short Fill

What should I do if I have this product?

Review the official FDA enforcement record for current instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot #: 126451 Exp. 04/30/2023

Product
Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator (racephedrine, USP 11.25), 30x0.5 mL Sterile Vials each in a foil pouch, NDC…
Recalling firm
Nephron Sc Inc
Quantity
387,000 vials
Distribution
Nationwide within the United States including Puerto Rico. Guatamala
Recall date
February 1, 2023
Classification
Class II
Status
Terminated
Agency
FDA (drug)
Open FDA enforcement record Latest recalls